Home›Companies›Biotech & Pharma›InGeneron

InGeneron, Inc.

Updated Oct 29, 2026·Latest SEC filing Mar 4, 2024·Suggest an edit

About InGeneron

InGeneron is a private company based in Houston, Texas. It has reported $21,766,761 raised in five offerings on Form D since July 2016.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 16, 2024Mar 4, 2024$1,749,181fully sold10$174KEquityRule 506(b)Form D ↗
Apr 5, 2019Apr 18, 2019$3,500,000of $23.0M target1$3.5MEquityRule 506(b)Form D ↗
Feb 17, 2017Mar 6, 2017$9,867,575of $19.8M target4$2.4MEquityRule 506(b)Form D ↗
Aug 4, 2016Dec 20, 2016$2,150,000fully sold4$537KDebt, OptionsRule 506(b)Form D ↗
Oct 9, 2015Jul 7, 2016$4,500,005fully sold5$900KEquityRule 506(b)Form D ↗
Total, five offerings$21,766,761

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on InGeneron's Form D filed Mar 4, 2024.

AL
JG
KK
Klaus Keller
Director
BG
EA
Eckhard Alt
Executive officer and director
FA
Fabian Alt
Chief Financial Officer and director

Earlier filings also listed Ron Stubbers (executive officer, last listed Apr 2019), Kelby Krabbenhoft (director, last listed Apr 2019), Jerry Griffin, M.D. (director, last listed Apr 2019), Eckhard Alt, M.D., Ph.D. (director, last listed Apr 2019), Bobby Griffin, MS (director, last listed Apr 2019), Annette White (director, last listed Apr 2019), Angelo Moesslang (chief executive officer, last listed Apr 2019) and Michael Coleman (president, last listed Dec 2016).

Sources

  1. SECInGeneron, Inc. filing history